Genotype-Guided vs Clinical Dosing of Warfarin and Its Analogues
Authors:
- 1 August 2014
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 174 (8) , 1330-1338
Abstract
Research from JAMA Internal Medicine — Genotype-Guided vs Clinical Dosing of Warfarin and Its Analogues — Meta-analysis of Randomized Clinical TrialsKeywords
This publication has 38 references indexed in Scilit:
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Cardiovascular PharmacogenomicsCirculation Research, 2011
- A randomized controlled trial of genotype-based Coumadin initiationGenetics in Medicine, 2011
- Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of WarfarinJournal of General Internal Medicine, 2009
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic DataNew England Journal of Medicine, 2009
- Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of WarfarinClinical Pharmacology & Therapeutics, 2008
- Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral AnticoagulationCirculation, 2007
- Effect ofVKORC1Haplotypes on Transcriptional Regulation and Warfarin DoseNew England Journal of Medicine, 2005
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996